GWM
NOC icon

Geneos Wealth Management’s Northrop Grumman NOC Stock Holding History

Geneos Wealth Management’s Portfolio NOC Stock Details NOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$596K Sell
873
-72
-8% -$49.8K 0.01% 638
2025
Q4 		$539K Buy
945
+2
+0.2% +$1.16K 0.01% 640
2025
Q3 		$575K Sell
943
-1,511
-62% -$857K 0.01% 614
2025
Q2 		$1.23M Sell
2,454
-3,812
-61% -$1.87M 0.03% 483
2025
Q1 		$3.21M Buy
6,266
+4,217
+206% +$2.01M 0.05% 379
2024
Q4 		$962K Buy
2,049
+183
+10% +$92K 0.03% 431
2024
Q3 		$985K Buy
1,866
+1,279
+218% +$626K 0.04% 411
2024
Q2 		$256K Buy
587
+19
+3% +$8.68K 0.01% 644
2024
Q1 		$272K Sell
568
-6
-1% -$2.76K 0.01% 627
2023
Q4 		$269K Sell
574
-160
-22% -$75K 0.01% 600
2023
Q3 		$323K Buy
734
+63
+9% +$27.7K 0.02% 560
2023
Q2 		$306K Buy
671
+133
+25% +$60.3K 0.02% 587
2023
Q1 		$248K Sell
538
-347
-39% -$161K 0.02% 596
2022
Q4 		$483K Buy
885
+56
+7% +$29.2K 0.03% 433
2022
Q3 		$389K Sell
829
-526
-39% -$251K 0.03% 442
2022
Q2 		$658K Sell
1,355
-38
-3% -$17.5K 0.03% 423
2022
Q1 		$623K Buy
1,393
+84
+6% +$34.7K 0.03% 480
2021
Q4 		$506K Buy
1,309
+107
+9% +$39.9K 0.02% 573
2021
Q3 		$433K Hold
1,202
– – 0.02% 609
2021
Q2 		$443K Sell
1,202
-250
-17% -$90K 0.02% 586
2021
Q1 		$514K Hold
1,452
– – 0.01% 630
2020
Q4 		$384K Sell
1,452
-57
-4% -$17.4K 0.02% 615
2020
Q3 		$494K Buy
1,509
+13
+0.9% +$4.24K 0.03% 433
2020
Q2 		$451K Sell
1,496
-88
-6% -$28.9K 0.03% 434
2020
Q1 		$494K Sell
1,584
-114
-7% -$39.7K 0.03% 378
2019
Q4 		$588K Buy
1,698
+230
+16% +$80.9K 0.03% 408
2019
Q3 		$544K Buy
1,468
+132
+10% +$46.7K 0.03% 392
2019
Q2 		$431K Sell
1,336
-79
-6% -$23.6K 0.03% 445
2019
Q1 		$381K Buy
1,415
+132
+10% +$36K 0.03% 472
2018
Q4 		$310K Buy
1,283
+8
+0.6% +$2.21K 0.02% 478
2018
Q3 		$404K Buy
1,275
+94
+8% +$28.6K 0.03% 432
2018
Q2 		$363K Hold
1,181
– – 0.03% 390
2018
Q1 		$412K Buy
1,181
+1
+0.1% +$335 0.04% 347
2017
Q4 		$362K Sell
1,180
-34
-3% -$10.2K 0.03% 390
2017
Q3 		$349K Sell
1,214
-39
-3% -$10.5K 0.03% 373
2017
Q2 		$321K Buy
1,253
+9
+0.7% +$2.25K 0.03% 382
2017
Q1 		$296K Sell
1,244
-142
-10% -$33.7K 0.03% 389
2016
Q4 		$322K Sell
1,386
-47
-3% -$10.9K 0.04% 350
2016
Q3 		$306K Buy
1,433
+110
+8% +$23.8K 0.04% 351
2016
Q2 		$293K Buy
1,323
+100
+8% +$21.1K 0.04% 355
2016
Q1 		$245K Buy
+1,223
New +$231K 0.04% 390

Other funds holding NOC

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's NOC Position: Q1 2026 in Review

Geneos Wealth Management reduced its Northrop Grumman (NOC) stake by 7.6% in Q1 2026, selling an estimated $49.8K and leaving 873 shares worth $596K. The position accounts for 0.01% of the portfolio, ranked #638.

Geneos Wealth Management first reported a position in NOC in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.21M in Q1 2025. 1,875 funds tracked by Wall St. Rank hold NOC as of Q1 2026.

  • Geneos Wealth Management held 873 shares of Northrop Grumman worth $596K as of Q1 2026.
  • Geneos Wealth Management sold 72 Northrop Grumman shares in Q1 2026, an estimated $49.8K.
  • Northrop Grumman made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #638 holding.
  • Geneos Wealth Management first reported a position in Northrop Grumman in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Northrop Grumman position peaked at $3.21M in Q1 2025.
  • 1,875 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.